VRCA vs ZBH · rev $10.9M vs P/E 23, rev $4.26B
Verrica Pharmaceuticals Inc (VRCA) versus Zimmer Biomet Holdings Inc (ZBH) — a side-by-side from cached financials, not a winner call.
Verrica Pharmaceuticals Inc (VRCA) is a biotechnology company listed on US.
Zimmer Biomet Holdings Inc (ZBH) is a medical devices company listed on NYSE.
Latest reported VRCA revenue for 2026-06-30 was $10.9M. Net income was -$22.8M. VRCA currently screens at market cap $79.7M.
Latest reported ZBH revenue for 2026-06-30 was $4.26B. Net income was $436.5M. ZBH currently screens at market cap $17.13B and trailing P/E 22.9.
VRCA currently screens at market cap $79.7M. ZBH currently screens at market cap $17.13B and trailing P/E 22.9.
Not investment advice. Open the VRCA and ZBH stock pages for the full models.
Not investment advice.